Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Meloni (Pavia, Italy), R. Di Paola (Messina, Italy), P. Morbini (Pavia, Italy), L. Pandolfi (Pavia, Italy), V. Frangipane (Pavia, Italy), E. Gugliandolo (Messina, Italy), E. Cova (Pavia, Italy), M. Colombo (Milano, Italy), D. Prosperi (Milano, Italy), P. Vitulo (Palermo, Italy), G. Ferrario (Pavia, Italy), R. Fusco (Pavia, Italy), C. Pacini (Milano, Italy), R. Siracusa (Milano, Italy), S. Cuzzocrea (Messina, Italy). Efficacy of imatinib loaded-antiCD44 coated gold nanoparticles: a possible new therapeutic approach to BOS. 3361

Member's Comments

No comment yet.

Related content which might interest you: Polyacrylate nanoparticles: toxicity or new nanomedicine? Source: Eur Respir J 2010; 36: 218-221 Year: 2010 Therapeutic algorithm: gold standard and new approaches Source: Annual Congress 2009 - Central sleep apnoea: new challenges, new opportunities Year: 2009 The antifibrotic effect of Imatinib loaded CD44 targeted gold nanoparticles (Im-CD44-GNP) relies on alveolar macrophage regulation Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung Source: Annual Congress 2009 - New drugs for airways disease Year: 2009 Bioresorbable polymer structures - promising carriers for prolonged forms of anti-tuberculosis drugs Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Late Breaking Abstract - Aerosolized gold nanoparticles as a vehicle for prolonged donor lung treatment Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Assessing the therapeutic benefit of a new inhaled QD LABA through population PK-safety & efficacy modelling Source: Annual Congress 2009 - New bronchodilators Year: 2009 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 Highly efficient dual and triple combination therapies with no coformulation effect for treatment of COPD Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012 Inhalable Ciprofloxacin-Nanoplex (CIP-Np) combined with mannitol as a novel bronchiectasis therapeutic Source: International Congress 2017 – From microbiology to clinical work Year: 2017 The MABA approach: a new option to improve bronchodilator therapy Source: Eur Respir J 2013; 42: 885-887 Year: 2013 Combinatorial delivery of targeted mesoporous silica nanoparticles for lung cancer therapy Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future? Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 Effect of long-term imatinib treatment in a severe preclinical PAH rat model: An insight into pulmonary perfusion using a novel casting method Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Drug loaded liposomes of mesalamine incorporated into disease responsive microgels (Micro) for treating allergic asthma: An approach using smart drug delivery system Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Improvement of QVAR delivery through a better sorting of drug particles: development of an innovative and easy-to-use spacer Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Novel paradigm for inhaled therapies: simulation of drug pharmacokinetic behaviour and effect of disease Source: Eur Respir J 2003; 22: Suppl. 45, 474s Year: 2003